Atlas Trials

The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes

Clinical trial NCT06318442 · RECRUITING

Trial details

NCT number
NCT06318442
Sponsor
Imperial College London
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Steroid-Induced DiabetesSteroid Induced Hyperglycemia
Start date
2024-05-15
Primary completion
2027-06-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.